Insulin Resistance in Mitochondrial Diabetes

Chika Takano, Erika Ogawa, Satoshi Hayakawa

Research output: Contribution to journalReview articlepeer-review

9 Citations (Scopus)


Mitochondrial diabetes (MD) is generally classified as a genetic defect of β-cells. The main pathophysiology is insulin secretion failure in pancreatic β-cells due to impaired mitochondrial ATP production. However, several reports have mentioned the presence of insulin resistance (IR) as a clinical feature of MD. As mitochondrial dysfunction is one of the important factors causing IR, we need to focus on IR as another pathophysiology of MD. In this special issue, we first briefly summarized the insulin signaling and molecular mechanisms of IR. Second, we overviewed currently confirmed pathogenic mitochondrial DNA (mtDNA) mutations from the MITOMAP database. The variants causing diabetes were mostly point mutations in the transfer RNA (tRNA) of the mitochondrial genome. Third, we focused on these variants leading to the recently described “tRNA modopathies” and reviewed the clinical features of patients with diabetes. Finally, we discussed the pathophysiology of MD caused by mtDNA mutations and explored the possible mechanism underlying the development of IR. This review should be beneficial to all clinicians involved in diagnostics and therapeutics related to diabetes and mitochondrial diseases.

Original languageEnglish
Article number126
Issue number1
Publication statusPublished - Jan 2023


  • insulin resistance
  • mitochondrial DNA mutation
  • mitochondrial diabetes
  • transfer RNA modopathy


Dive into the research topics of 'Insulin Resistance in Mitochondrial Diabetes'. Together they form a unique fingerprint.

Cite this